Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Non-Current Deffered Revenue (2018 - 2025)

Inventiva (IVEVF) posted Non-Current Deffered Revenue of $146669.5 for Q4 2025, up 2.83% on a QoQ basis from $142626.9 in Q2 2025, and up 28.28% year-over-year from $114339.7 in Q4 2024.

Analysis

Inventiva (IVEVF) Non-Current Deffered Revenue (2018 - 2025) Analysis & Trends

Inventiva has reported Non-Current Deffered Revenue for 5 years, with the latest figure at $146669.5 in Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue rose 28.28% year-over-year to $146669.5 in Q4 2025; TTM through Dec 2025 was $146669.5, a 28.28% increase from a year earlier, with the FY2025 full-year figure at $146669.5, up 28.28% from the prior year.
  • Non-Current Deffered Revenue was $146669.5 for Q4 2025 at Inventiva, up from $142626.9 in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $146669.5 in Q4 2025, with the low at $56113.6 in Q4 2022.
  • Average Non-Current Deffered Revenue over 4 years is $100248.3, with a median of $94827.8 recorded in 2023.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Deffered Revenue soared 51.81% in 2024, then advanced 28.28% in 2025.
  • Over 4 years, Non-Current Deffered Revenue stood at $56113.6 in 2022, then surged by 34.22% to $75315.8 in 2023, then soared by 51.81% to $114339.7 in 2024, then advanced by 28.28% to $146669.5 in 2025.
  • The last three Non-Current Deffered Revenue figures came in at $146669.5 (Q4 2025), $142626.9 (Q2 2025), and $114339.7 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 646.53 Bn 625.77 Bn 17.26 Bn -
2 AbbVie 442.27 Bn 435.70 Bn 12.70 Bn -
3 Merck 366.81 Bn 359.67 Bn 12.21 Bn -
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn -
5 Pfizer 159.37 Bn 147.67 Bn 10.94 Bn -
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn -
7 Revolution Medicines 44.12 Bn 44.12 Bn - -
8 Incyte 25.49 Bn 20.95 Bn 1.57 Bn -
9 United Therapeutics 21.55 Bn 18.89 Bn 683.80 Mn -
10 Inventiva 693.72 Mn 693.72 Mn - 146,669.48
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 146,669.48
Jun 30, 2025 142,626.92
Dec 31, 2024 114,339.71
Dec 31, 2023 75,315.79
Jun 30, 2023 66,424.39
Dec 31, 2022 56,113.61
Dec 31, 2018 1.91 Mn